<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Attention has focused on whether normalization, regression, and development of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in specialized <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (SIM) differ among long-segment <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (LSBE), short-segment BE (SSBE), and esophagogastric junction SIM (EGJSIM) </plain></SENT>
<SENT sid="1" pm="."><plain>We prospectively followed a cohort of SIM patients receiving long-term antisecretory medications to determine: (a) histologic normalization (no evidence of SIM on biopsy), (b) change in SIM length, (c) incidence of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and (d) factors associated with normalization </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: One hundred forty-eight patients with SIM were identified in our original cohort </plain></SENT>
<SENT sid="3" pm="."><plain>Of these, 60.5% (23/38) LSBE, 69.8% (44/63) SSBE, and 72.3% (34/47) EGJSIM patients underwent repeat surveillance over a mean 44.4 +/- 9.7 months </plain></SENT>
<SENT sid="4" pm="."><plain>Demographic, clinical, and endoscopic data were obtained </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: (a) With long-term, antisecretory therapy, normalization occurred in 0/23 LSBE, 30% (13/44) of SSBE, and 68% (23/34) of EGJSIM (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>(b) Normalization was more likely with EGJSIM (odds ratio [OR] 6.7, CI 2.3-19.3, P= 0.005), female gender (OR 7.3, CI 2.3-23.1, P= 0.001), or absence of <z:hpo ids='HP_0002036'>hiatal hernia</z:hpo> (OR 2.9, CI 1.02-8.06, P= 0.002) </plain></SENT>
<SENT sid="7" pm="."><plain>(c) A significant decrease in mean SIM length was noted for the entire population (2.5 +/- 0.3 to 2.13 +/- 0.3 cm, P= 0.004) </plain></SENT>
<SENT sid="8" pm="."><plain>(d) Follow-up incidence of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was 26.1% (3 indefinite, 2 low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> [LGD], 1 cancer) for LSBE, 6.8% (2 indefinite, 1 LGD) for SSBE, and none for EGJSIM (P &lt; 0.004) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: (a) Normalization of SIM occurs most frequently in EGJSIM&gt;SSBE&gt;LSBE </plain></SENT>
<SENT sid="10" pm="."><plain>(b) Factors associated with normalization favor less severe GER and shorter segments of SIM </plain></SENT>
<SENT sid="11" pm="."><plain>(c) Surveillance of LSBE results in the greatest yield for identifying <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>